FLYNN JAMES E purchased 4.29M shares of LARIMAR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $37.50M. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 2/16/2024ACC: 0001193805-24-000245
Director10% OwnerOther
Since May 2020
+4.29M
Net shares
Net buyer
$37.50M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
4.29M acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+1.43M
Price / share
$8.74
Trade value
$12.50M
% of position
30.3%
2/16/2024
4.72M→6.15M
Common Stock
Indirect
Shares
+1.43M
Price / share
$8.74
Trade value
$12.50M
% of position
30.3%
2/16/2024
4.72M→6.15M
Common Stock
Indirect
Shares
+1.43M
Price / share
$8.74
Trade value
$12.50M
% of position
51.5%
2/16/2024
2.78M→4.21M
Total
Net shares
+4.29M
Net value
$37.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/16/2024 | P · Purchase | +1.43M | $8.74 | $12.50M | 30.3% | 4.72M | 6.15M |
| Common Stock Indirect | 2/16/2024 | P · Purchase | +1.43M | $8.74 | $12.50M | 30.3% | 4.72M | 6.15M |
| Common Stock Indirect | 2/16/2024 | P · Purchase | +1.43M | $8.74 | $12.50M | 51.5% | 2.78M | 4.21M |
| Total | +4.29M | $37.50M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.72M
Total
4.72M indirect4.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.72M | Indirect |
| Total | 4.72M | 4.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported